Physician profile
Donald E Davis
NPI 1225017247
$859.47
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.20 · 2020: $43.35 · 2021: $57.18 · 2022: $168 · 2023: $91.12 · 2024: $295 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $190.49 | 2019-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $133.60 | 2024-2025 | Sotyktu |
| Amgen INC. | $91.25 | 2020-2024 | Otezla |
| Lilly USA, LLC | $61.98 | 2022-2025 | Taltz, Ebglyss |
| Verrica Pharmaceuticals INC. | $53.81 | 2023-2025 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.94 | 2023-2025 | Spevigo |
| Janssen Biotech, INC. | $43.90 | 2019-2022 | |
| Strata Skin Sciences, INC. | $34.40 | 2022-2025 | Xtrac |
| Galderma Laboratories, L.P. | $32.85 | 2023-2025 | Aklief, Nemluvio |
| Ucb, INC. | $27.71 | 2023-2024 | Cimzia, Bimzelx |
| Leo Pharma INC. | $25.39 | 2022 | |
| Kyowa Kirin, INC. | $23.50 | 2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $20.12 | 2024 | |
| Dermavant Sciences, INC. | $18.35 | 2024 | Vtama |
| Genzyme Corporation | $16.85 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $13.83 | 2022 | |
| Celgene Corporation | $13.29 | 2019 | |
| Incyte Corporation | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.